Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV

Journal of Viral Hepatitis

Volumn 23, Issue 2, 2016, Pages 116-122

  Carmo, R F ^a,b   Aroucha, D ^c,d   Vasconcelos, L R S ^c,e   Pereira, L M M B ^c,d   Moura, P ^d   Cavalcanti, M S M ^b,d  

^a UNIVERSIDADE FEDERAL DO VALE DO SÃO FRANCISCO   (Brazil)

^b Rede Nordeste de Biotecnologia (RENORBIO)   (Brazil)

^c Instituto Do Figado and Transplants of Pernambuco   (Brazil)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

fibrosis; hepatitis C; hepatitis C virus; hepatocellular carcinoma; pentraxin 3; polymorphism

Indexed keywords

PENTRAXIN 3; C REACTIVE PROTEIN; SERUM AMYLOID P;

ADULT; ARTICLE; CHILD PUGH SCORE; CHRONIC HEPATITIS C; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PTX3 GENE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; BLOOD; GENETICS; HEPACIVIRUS; LIVER CIRRHOSIS; LIVER TUMOR; METABOLISM; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; VIROLOGY;

C-REACTIVE PROTEIN; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SERUM AMYLOID P-COMPONENT;

EID: 84955625410     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12472     Document Type: Article

References (31)

1. Lavanchy D,. The global burden of hepatitis C. Liver Int 2009; 29 (Suppl. 1): 74-81.
2. Hoshida Y, Fuchs BC, Bardeesy N, Baumert TF, Chung RT,. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. J Hepatol 2014; 61 (1 Suppl.): S79-S90.
3. Wang YY, Lo GH, Lai KH, Cheng JS, Lin CK, Hsu PI,. Increased serum concentrations of tumor necrosis factor-alpha are associated with disease progression and malnutrition in hepatocellular carcinoma. J Chin Med Assoc 2003; 66: 593-598.
4. Mondelli MU, Barnaba V,. Viral and host immune regulatory mechanisms in hepatitis C virus infection. Eur J Gastroenterol Hepatol 2006; 18: 327-331.
5. Farinati F, Cardin R, Bortolami M, et al,. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat 2007; 14: 821-829.
6. Aroucha DC, do Carmo RF, Moura P, et al,. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C. Cytokine 2013; 62: 421-425.
7. Bottazzi B, Vouret-Craviari V, Bastone A, et al,. Multimer formation and ligand recognition by the long pentraxin PTX3.Similarities and differences with the short pentraxins C-reactive proteinand serum amyloid P component. J Biol Chem 1997; 272: 32817-32823.
8. Nauta AJ, Daha MR, van Kooten C, Roos A,. Recognition and clearance of apop-totic cells: a role for complement and pentraxins. Trends Immunol 2003; 24: 148-154.
9. Inforzato A, Doni A, Barajon I, et al,. PTX3 as a paradigm for the interaction of pentraxins with the complement system. Semin Immunol 2013; 25: 79-85.
10. Diamond JM, Meyer NJ, Feng R, et al,. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2012; 186: 546-552.
11. Barbati E, Specchia C, Villella M, et al,. Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels. PLoS ONE 2012; 7: e53030.
12. Olesen R, Wejse C, Velez DR, et al,. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 2007; 8: 456-467.
13. Chiarini M, Sabelli C, Melotti P, et al,. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun 2010; 11: 665-670.
14. Choi B, Lee EJ, Park YS, et al,. Pentraxin-3 silencing suppresses gastric cancer-related inflammation by inhibiting chemotactic migration of macrophages. Anticancer Res 2015; 35: 2663-2668.
15. Diamandis EP, Goodglick L, Planque C, Thornquist MD,. Pentraxin-3 is a novel biomarker of lung carcinoma. Clin Cancer Res 2011; 17: 2395-2399.
16. Kondo S, Ueno H, Hosoi H, et al,. Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma. Br J Cancer 2013; 109: 739-746.
17. Germano G, Frapolli R, Simone M, et al,. Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells. Cancer Res 2010; 70: 2235-2244.
18. Stallone G, Cormio L, Netti GS, et al,. Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer. Cancer Res 2014; 74: 4230-4238.
19. Locatelli M, Ferrero S, Martinelli Boneschi F, et al,. The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas. J Neuroimmunol 2013; 260: 99-106.
20. Hoshida Y, Fuchs BC, Tanabe KK,. Genomic risk of hepatitis C-related hepatocellular carcinoma. J Hepatol 2012 Mar; 56: 729-730.
21. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293.
22. Bruix J, Sherman M,. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
23. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R,. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
24. Souza DG, Soares AC, Pinho V, et al,. Increased mortality and inflammation in tumor necrosis factor-stimulatedgene-14 transgenic mice after ischemia and reperfusion injury. Am J Pathol 2002; 160: 1755-1765.
25. Chen J, Matzuk MM, Zhou XJ, Lu CY,. Endothelial pentraxin 3 con-tributes to murine ischemic acute kidney injury. Kidney Int 2012; 82: 1195-1207.
26. Real JM, Spilborghs GM, Morato-Marques M, et al,. Pentraxin 3 accelerates lung injury in high tidal volume ventilation in mice. Mol Immunol 2012; 51: 82-90.
27. Daigo K, Mantovani A, Bottazzi B,. The yin-yang of long pentraxin PTX3 in inflammation and immunity. Immunol Lett 2014; 161: 38-43.
28. Souza DG, Amaral FA, Fagundes CT, et al,. The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. Am J Pathol 2009; 174: 1309-1318.
29. Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ,. Viral hepatocarcinogenesis: from infection to cancer. Liver Int 2008; 28: 175-188.
30. Pilling D, Cox N, Vakil V, Verbeek JS, Gomer RH,. The long pentraxin PTX3 promotes fibrocyte differentiation. PLoS ONE 2015; 10: e0119709.
31. Choi B, Lee EJ, Song DH, et al,. Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function. Oncotarget 2014; 5: 481-492.